Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function

Journal of Investigative Dermatology

Volumn 133, Issue 2, 2013, Pages 469-478

  Lin, Tzu Kai ^a,b   Man, Mao Qiang ^a   Santiago, Juan Luis ^a,c   Park, Kyungho ^a   Roelandt, Truus ^a,d   Oda, Yuko ^a   Hupe, Melanie ^a   Crumrine, Debra ^a   Lee, Hae Jin ^e   Gschwandtner, Maria ^f   Thyssen, Jacob P ^a,g   Trullas, Carles ^h   Tschachler, Erwin ^f   Feingold, Kenneth R ^a,i   Elias, Peter M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

^d UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^e Yonsei University Wonju   (South Korea)

^f Universitatsklinik fur Dermatologie   (Austria)

^g GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^h ISDIN   (Spain)

ⁱ SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; LIPID;

ACUTE ALLERGIC CONTACT DERMATITIS; ACUTE ATOPIC DERMATITIS; ACUTE IRRITANT CONTACT DERMATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; EPIDERMIS; FEMALE; HISTAMINE RELEASE; HOMEOSTASIS; IMMUNOLOGICAL PARAMETERS; INFLAMMATION; IRRITANT DERMATITIS; LIPOGENESIS; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; SKIN ALLERGY; SKIN FUNCTION; SKIN PERMEABILITY; SUBACUTE ALLERGIC CONTACT DERMATITIS;

EID: 84872603337     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.335     Document Type: Article

References (61)

1. Ashida Y, Denda M, Hirao T (2001) Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment. J Invest Dermatol 116:261-5
2. Baumer W, Stahl J, Sander K et al. (2011) Lack of preventing effect of systemically and topically administered histamine H(1) or H(4) receptor antagonists in a dog model of acute atopic dermatitis. Exp Dermatol 20:577-81
3. Belsito DV, Kerdel FA, Potozkin J et al. (1990) Cimetidine-induced augmentation of allergic contact hypersensitivity reactions in mice. J Invest Dermatol 94:441-5
4. Buddenkotte J, Maurer M, Steinhoff M (2010) Histamine and antihistamines in atopic dermatitis. Adv Exp Med Biol 709:73-80
5. Chen H, Toh TK, Szeverenyi I et al. (2009) Association of skin barrier genes within the PSORS4 locus is enriched in Singaporean Chinese with early-onset psoriasis. J Invest Dermatol 129:606-14
6. Denda M (2002) New strategies to improve skin barrier homeostasis. Adv Drug Deliv Rev 54:S123-30
7. Denda M, Nakatani M, Ikeyama K et al. (2007) Epidermal keratinocytes as the forefront of the sensory system. Exp Dermatol 16:157-61
8. Diepgen TL (2002) Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol 13:278-86
9. Elias P, Williams M, Crumrine D et al. (2010) Ichthyoses-clinical, biochemical, pathogenic, and diagnostic assessment, 39. S. Kargar AG: Basel, 144p
10. Elias P, Wood L, Feingold K (1997) Relationship of the epidermal permeability barrier to irritant contact dermatitis. Immunol Allergy Clin North America 17:417-30
11. Elias PM (2006) The epidermal permeability barrier: from Saran Wrap to biosensor. In Skin Barrier (Elias PM, Feingold KR eds), Taylor & Francis: New York, 25-31
12. Elias PM (2010) Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Ann Dermatol 22:245-54
13. Elias PM, Feingold KR (2001) Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch Dermatol 137:1079-81
14. Elias PM, Hatano Y, Williams ML (2008a) Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 121:1337-43
15. Elias PM, Menon GK (1991) Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 24:1-26
16. Elias PM, Schmuth M (2009) Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol 9:437-46
17. Elias PM, Steinhoff M (2008) 'Outside-to-inside' (and now back to "outside") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 128:1067-70
18. Elias PM, Wakefield JS (2011) Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Clin Rev Allergy Immunol 41:282-95
19. Elias PM, Williams ML, Holleran WM et al. (2008b) Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism. J Lipid Res 49:697-714
20. Elias PM, Wood LC, Feingold KR (1999) Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat 10:119-26
21. Endo Y, Kikuchi T, Takeda Y et al. (1992) GM-CSF and G-CSF stimulate the synthesis of histamine and putrescine in the hematopoietic organs in vivo. Immunol Lett 33:9-13
22. Endo Y, Nakamura M, Nitta Y et al. (1995) Effects of macrophage depletion on the induction of histidine decarboxylase by lipopolysaccharide, inter-leukin 1 and tumour necrosis factor. Br J Pharmacol 114:187-93
23. Eschler DC, Klein PA (2010) An evidence-based review of the efficacy of topical antihistamines in the relief of pruritus. J Drugs Dermatol 9:992-7
24. Feingold KR (2007) Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 48:2531-46
25. Feingold KR (2009) The outer frontier: the importance of lipid metabolism in the skin. J Lipid Res 50:S417-22
26. Fowler AJ, Sheu MY, Schmuth M et al. (2003) Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J Invest Dermatol 120:246-55
27. Greaves MW (2005) Antihistamines in dermatology. Skin Pharmacol Physiol 18:220-9
28. Gschwandtner M, Mommert S, Kother B et al. (2011) The histamine H4 receptor is highly expressed on plasmacytoid dendritic cells in psoriasis and histamine regulates their cytokine production and migration. J Invest Dermatol 131:1668-76
29. Gunathilake R, Schmuth M, Scharschmidt TC et al. (2010) Epidermal barrier dysfunction in non-atopic HIV: evidence for an 'inside-to-outside' pathogenesis. J Invest Dermatol 130:1185-8
30. Hatano Y, Man MQ, Uchida Y et al. (2009) Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis. J Invest Dermatol 129:1824-35
31. Hatano Y, Man MQ, Uchida Y et al. (2010) Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators. J Allergy Clin Immunol 125:160-9
32. Hill SJ, Ganellin CR, Timmerman H et al. (1997) International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49:253-78
33. Irvine AD, McLean WH, Leung DY (2011) Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 365:1315-27
34. Janssens AS, Heide R, den Hollander JC et al. (2005) Mast cell distribution in normal adult skin. J Clin Pathol 58:285-9
35. Kawashima M, Tango T, Noguchi T et al. (2003) Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. Br J Dermatol 148:1212-21
36. Kim SY, Bae CD (1998) Calpain inhibitors reduce the cornified cell envelope formation by inhibiting proteolytic processing of transglutaminase 1. Exp Mol Med 30:257-62
37. Klein PA, Clark RA (1999) An evidence-based review of the efficacy of antihista-mines in relieving pruritus in atopic dermatitis. Arch Dermatol 135:1522-5
38. Kobayashi M, Kabashima K, Nakamura M et al. (2009) Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and CD54 expression in human keratinocytes. Skin Pharmacol Physiol 22:45-8
39. Koizumi H, Ohkawara A (1999) H2 histamine receptor-mediated increase in intracellular Ca2+ in cultured human keratinocytes. J Dermatol Sci 21:127-32
40. Komuves LG, Hanley K, Man MQ et al. (2000) Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis. J Invest Dermatol 115:361-7
41. Levi-Schaffer F, Eliashar R (2009) Mast cell stabilizing properties of antihista-mines. J Invest Dermatol 129:2549-51
42. Man MQ, Choi EH, Schmuth M et al. (2006) Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing. J Invest Dermatol 126:386-92
43. Man MQ, Feingold KR, Elias PM (1993) Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol 129:728-38
44. Man MQ, Hatano Y, Lee SH et al. (2008) Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol 128:79-86
45. Matsubara M, Tamura T, Ohmori K et al. (2005) Histamine H1 receptor antagonist blocks histamine-induced proinflammatory cytokine production through inhibition of Ca2+-dependent protein kinase C, Raf/MEK/ERK and IKK/I kappa B/NF-kappa B signal cascades. Biochem Pharmacol 69:433-49
46. Nemes Z, Steinert PM (1999) Bricks and mortar of the epidermal barrier. Exp Mol Med 31:5-19
47. Nickoloff BJ, Naidu Y (1994) Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 30:535-46
48. Oda T, Morikawa N, Saito Y et al. (2000) Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275:36781-6
49. Pavlinkova G, Yanagawa Y, Kikuchi K et al. (2003) Effects of histamine on functional maturation of dendritic cells. Immunobiology 207:315-25
50. Sandilands A, Sutherland C, Irvine AD et al. (2009) Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 122:1285-94
51. Schmuth M, Gruber R, Elias PM et al. (2007) Ichthyosis update: towards a function-driven model of pathogenesis of the disorders of cornification and the role of corneocyte proteins in these disorders. Adv Dermatol 23:231-56
52. Schmuth M, Jiang YJ, Dubrac S et al. (2008) Thematic Review Series: Skin Lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. J Lipid Res 49:499-509
53. Sheu MY, Fowler AJ, Kao J et al. (2002) Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. J Invest Dermatol 118:94-101
54. Shimizu T, Nishihira J, Watanabe H et al. (2004) Cetirizine, an H1-receptor antagonist, suppresses the expression of macrophage migration inhibitory factor: its potential anti-inflammatory action. Clin Exp Allergy 34:103-9
55. Strange A, Capon F, Spencer CC et al. (2010) A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 42:985-90
56. Sun C, Mathur P, Dupuis J et al. (2006) Peptidoglycan recognition proteins Pglyrp3 and Pglyrp4 are encoded from the epidermal differentiation complex and are candidate genes for the Psors4 locus on chromosome 1q21. Hum Genet 119:113-25
57. Travis ER, Wang YM, Michael DJ et al. (2000) Differential quantal release of histamine and 5-hydroxytryptamine from mast cells of vesicular mono-amine transporter 2 knockout mice. Proc Natl Acad Sci USA 97:162-7
58. Tschachler E (2007) Psoriasis: the epidermal component. Clin Dermatol 25:589-95
59. Wang KY, Tanimoto A, Yamada S et al. (2010) Histamine regulation in glucose and lipid metabolism via histamine receptors: model for nonalcoholic steatohepatitis in mice. Am J Pathol 177:713-23
60. Wood LC, Jackson SM, Elias PM et al. (1992) Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-7
61. Yamaguchi K, Motegi K, Kurimoto M et al. (2000) Induction of the activity of the histamine-forming enzyme, histidine decarboxylase, in mice by IL-18 and by IL-18 plus IL-12. Inflamm Res 49:513-9